BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 11:31:00 AM | Browse: 1369 | Download: 1487
 |
Received |
|
2013-09-28 21:44 |
|
Peer-Review Started |
|
2013-09-30 11:51 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-11-15 14:32 |
|
Revised |
|
2013-12-06 05:04 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-03-06 17:47 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-03-06 18:21 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-03-26 16:44 |
|
Publish the Manuscript Online |
|
2014-04-17 13:27 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ali Raza and Gagan K Sood |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gagan K Sood, MD, Division of Gastroenterology and Hepatology, Baylor College of Medicine, St. Luke’s Liver Center, 6620 Main Street, Suite 1425, Baylor Clinic, Houston, TX 77030, United States. gksood@bcm.edu |
| Key Words |
Hepatocellular carcinoma; Trans-arterial chemoembolization; Drug-eluting beads; Radiofrequency ablation; Liver transplantation; Chemotherapy; Sorafenib; Radioembolization |
| Core Tip |
The article discusses the current evidence based treatment of hepatocellular carcinoma. Specific focus is placed on emerging systemic molecular targeted therapies.
|
| Publish Date |
2014-04-17 13:27 |
| Citation |
Raza A, Sood GK. Hepatocellular carcinoma review: Current treatment, and evidence-based medicine. World J Gastroenterol 2014; 20(15): 4115-4127
|
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i15/4115.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i15.4115 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
